Amal Taher Elhaw

8PUBLICATIONS
63CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 30, 2026
The chemotherapy-induced senescence-associated secretome promotes cell detachment and metastatic dissemination through metabolic reprogramming.

|Apr 16, 2026
RHOV Is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis.

|Aug 20, 2025
RHOV is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis.

Amal T Elhaw, Priscilla W Tang, Ya-Yun Cheng

|Jul 09, 2025
Loss of Predicted Cell Adhesion Molecule MPZL3 Promotes EMT in Ovarian Cancer.

Ya-Yun Cheng, Beth L Worley, Zaineb Javed

|Mar 14, 2025
Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation.

Geyon L Garcia, Taylor Orellana, Grace Gorecki

|Nov 28, 2024
Loss of the predicted cell adhesion molecule MPZL3 promotes EMT and chemoresistance in ovarian cancer.

Ya-Yun Cheng, Beth L Worley, Zaineb Javed

Pageof 2

Frequent Collaborators

7 joint publications

Sierra White

7 joint publications

Katherine M Aird

7 joint publications

Nadine Hempel

6 joint publications

Ya-Yun Cheng